Camp4 Therapeutics CAMP
NASDAQ CAMP
$4.41 -0.08 (-1.79%)
As of: Sep 4, 2026 · 3:59 PM EDT

Camp4 Therapeutics (CAMP) Receivables (2024 - 2025)

Camp4 Therapeutics (CAMP) posted Receivables of $400000.0 for Q3 2025, little changed sequentially from $400000.0 in Q2 2025, and down 63.64% YoY from $1.1 million in Q3 2024.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Camp4 Therapeutics (CAMP) Receivables (2024 - 2025) Analysis & Trends

Camp4 Therapeutics has reported Receivables for 2 years, with the latest figure at $400000.0 in Q3 2025.

Peer Set

Peer Comparison

All peers
# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 2.13 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 6.57 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.93 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 160.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.06 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 912.74 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 215.33 Mn
10 Camp4 Therapeutics 260.10 Mn 260.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 400,000.00
Jun 30, 2025 400,000.00
Sep 30, 2024 1.10 Mn